| Primary |
| Colon Cancer |
19.6% |
| Rectal Cancer |
17.4% |
| Colorectal Cancer |
9.3% |
| Gastric Cancer |
6.4% |
| Premedication |
5.8% |
| Colon Cancer Metastatic |
4.8% |
| Non-small Cell Lung Cancer |
4.2% |
| Constipation |
3.2% |
| Glioblastoma |
3.2% |
| Congestive Cardiomyopathy |
2.9% |
| Diabetes Mellitus |
2.9% |
| Diarrhoea |
2.6% |
| Fluid Replacement |
2.6% |
| Pancreatic Carcinoma |
2.6% |
| Colorectal Cancer Metastatic |
2.3% |
| Hypertension |
2.3% |
| Prophylaxis |
2.3% |
| Asthma |
1.9% |
| Gastritis Prophylaxis |
1.9% |
| Rectal Cancer Metastatic |
1.9% |
|
| Thrombocytopenia |
11.1% |
| Tachycardia |
9.3% |
| Death |
7.4% |
| White Blood Cell Count Decreased |
7.4% |
| Interstitial Lung Disease |
5.6% |
| Neutropenia |
5.6% |
| Vomiting |
5.6% |
| Gastric Perforation |
3.7% |
| Hepatic Steatosis |
3.7% |
| Hyperkalaemia |
3.7% |
| Neutrophil Count Decreased |
3.7% |
| Prothrombin Time Shortened |
3.7% |
| Pulmonary Embolism |
3.7% |
| Pyrexia |
3.7% |
| Rash |
3.7% |
| Renal Failure |
3.7% |
| Sepsis |
3.7% |
| Septic Shock |
3.7% |
| Skin Reaction |
3.7% |
| Skin Ulcer |
3.7% |
|
| Secondary |
| Colorectal Cancer |
42.9% |
| Vomiting |
17.1% |
| Colon Cancer |
11.5% |
| Rectal Cancer |
6.2% |
| Drug Use For Unknown Indication |
3.2% |
| Colorectal Cancer Metastatic |
2.5% |
| Colon Cancer Metastatic |
2.1% |
| Hypertension |
2.0% |
| Small Cell Lung Cancer |
1.6% |
| Ischaemic Heart Disease Prophylaxis |
1.5% |
| Prophylaxis Of Nausea And Vomiting |
1.5% |
| Gastric Cancer |
1.3% |
| Neuroendocrine Carcinoma |
1.0% |
| Premedication |
1.0% |
| Constipation |
0.9% |
| Blood Cholesterol Increased |
0.7% |
| Congestive Cardiomyopathy |
0.7% |
| Dyspepsia |
0.7% |
| Faeces Hard |
0.7% |
| Product Used For Unknown Indication |
0.7% |
|
| Thrombocytopenia |
18.4% |
| Pulmonary Embolism |
10.5% |
| Vomiting |
10.5% |
| Sepsis |
9.6% |
| Palmar-plantar Erythrodysaesthesia Syndrome |
7.9% |
| Neutropenia |
6.1% |
| Tumour Thrombosis |
5.3% |
| White Blood Cell Count Decreased |
4.4% |
| Muscle Spasms |
3.5% |
| Radiation Pneumonitis |
3.5% |
| Febrile Neutropenia |
2.6% |
| Interstitial Lung Disease |
2.6% |
| Nausea |
2.6% |
| Anaphylactoid Reaction |
1.8% |
| Blood Pressure Increased |
1.8% |
| Colitis |
1.8% |
| Hepatitis Cholestatic |
1.8% |
| Hyperkalaemia |
1.8% |
| Melaena |
1.8% |
| Myalgia |
1.8% |
|
| Concomitant |
| Colon Cancer |
23.5% |
| Prophylaxis |
14.0% |
| Colon Cancer Metastatic |
13.3% |
| Colorectal Cancer Metastatic |
7.2% |
| Cancer Pain |
6.8% |
| Colorectal Cancer |
6.4% |
| Premedication |
4.5% |
| Mycosis Fungoides |
3.4% |
| Prophylaxis Of Nausea And Vomiting |
2.7% |
| Cervix Carcinoma Recurrent |
2.3% |
| Metastases To Lymph Nodes |
1.9% |
| Non-small Cell Lung Cancer |
1.9% |
| Diffuse Large B-cell Lymphoma |
1.5% |
| Drug Use For Unknown Indication |
1.5% |
| Hepatic Cancer Metastatic |
1.5% |
| Metastases To Central Nervous System |
1.5% |
| Metastases To Lung |
1.5% |
| Metastases To Peritoneum |
1.5% |
| Rectal Neoplasm |
1.5% |
| Recurrent Cancer |
1.5% |
|
| Transient Ischaemic Attack |
10.8% |
| Interstitial Lung Disease |
8.1% |
| Somnolence |
8.1% |
| Cardiac Failure |
5.4% |
| Chest Pain |
5.4% |
| Convulsion |
5.4% |
| Death |
5.4% |
| Infected Skin Ulcer |
5.4% |
| Metastases To Liver |
5.4% |
| Septic Shock |
5.4% |
| Tachycardia |
5.4% |
| Tetany |
5.4% |
| Urticaria |
5.4% |
| Abscess Limb |
2.7% |
| Diarrhoea |
2.7% |
| Gastrointestinal Haemorrhage |
2.7% |
| Gastrointestinal Stoma Complication |
2.7% |
| Hypocalcaemia |
2.7% |
| Impetigo |
2.7% |
| Inappropriate Antidiuretic Hormone Secretion |
2.7% |
|
